Eli Lilly & Co. (LLY) Tops Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,255.40 +0.88%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.89, $0.14 better than the analyst estimate of $0.75. Revenue for the quarter came in at $4.96 billion versus the consensus estimate of $4.99 billion.
Eli Lilly & Co. sees FY2015 EPS of $3.40-$3.45, versus prior guidance of $3.20-$3.30 and the consensus of $3.28.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
